GarcÃa-Sánchez, D.; González-González, A.; GarcÃa-GarcÃa, P.; Reyes, R.; Pérez-Núñez, M.I.; Riancho, J.A.; Évora, C.; RodrÃguez-Rey, J.C.; Pérez-Campo, F.M.
Effective Osteogenic Priming of Mesenchymal Stem Cells through LNA-ASOs-Mediated Sfrp1 Gene Silencing. Pharmaceutics 2021, 13, 1277.
https://doi.org/10.3390/pharmaceutics13081277
AMA Style
GarcÃa-Sánchez D, González-González A, GarcÃa-GarcÃa P, Reyes R, Pérez-Núñez MI, Riancho JA, Évora C, RodrÃguez-Rey JC, Pérez-Campo FM.
Effective Osteogenic Priming of Mesenchymal Stem Cells through LNA-ASOs-Mediated Sfrp1 Gene Silencing. Pharmaceutics. 2021; 13(8):1277.
https://doi.org/10.3390/pharmaceutics13081277
Chicago/Turabian Style
GarcÃa-Sánchez, Daniel, Alberto González-González, Patricia GarcÃa-GarcÃa, Ricardo Reyes, MarÃa Isabel Pérez-Núñez, José A. Riancho, Carmen Évora, José Carlos RodrÃguez-Rey, and Flor M. Pérez-Campo.
2021. "Effective Osteogenic Priming of Mesenchymal Stem Cells through LNA-ASOs-Mediated Sfrp1 Gene Silencing" Pharmaceutics 13, no. 8: 1277.
https://doi.org/10.3390/pharmaceutics13081277
APA Style
GarcÃa-Sánchez, D., González-González, A., GarcÃa-GarcÃa, P., Reyes, R., Pérez-Núñez, M. I., Riancho, J. A., Évora, C., RodrÃguez-Rey, J. C., & Pérez-Campo, F. M.
(2021). Effective Osteogenic Priming of Mesenchymal Stem Cells through LNA-ASOs-Mediated Sfrp1 Gene Silencing. Pharmaceutics, 13(8), 1277.
https://doi.org/10.3390/pharmaceutics13081277
